Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Asset Growth
-3.02%
Quarterly · Period ending:
LCTX Asset Growth
Latest reported-3.02%period ending
Latest reported-3.02%period ending
LCTX Quarterly Asset Growth (QoQ) (0.00% → -3.02%)
Latest values, visible window
High-resolution chart · PNG
LCTX asset growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Asset Growth |
|---|---|
| -3.0247% | |
| -2.71% | |
| 25.5971% | |
| -1.2775% | |
| -18.7503% | |
| -1.294% | |
| 17.2102% | |
| -6.0388% | |
| -5.2368% | |
| 7.3887% | |
| -4.8364% | |
| -4.9558% | |
| -1.34% | |
| -8.4576% | |
| -5.7065% | |
| -3.5123% | |
| -5.9493% | |
| -17.2019% | |
| 33.0252% | |
| -2.6285% | |
| 5.3358% | |
| 18.5078% | |
| 4.7134% | |
| -8.0211% | |
| -5.7216% | |
| -5.2567% | |
| -5.64% | |
| -12.3363% | |
| -17.4313% | |
| 80.7151% | |
| -42.2639% | |
| 56.8601% | |
| 1.6812% | |
| -36.2766% | |
| -21.9167% | |
| 14.7471% | |
| -5.7807% | |
| 43.9385% | |
| -3.3895% | |
| 41.4533% | |
| 30.2232% | |
| -15.3666% | |
| 23.1606% | |
| -3.4556% | |
| 14.2124% | |
| -6.9391% | |
| 34.5815% | |
| -15.6561% | |
| 13.8664% | |
| 0.3813% | |
| 87.1082% | |
| -22.6604% | |
| 13.0219% | |
| 18.6523% | |
| -9.4971% | |
| -14.3587% | |
| -1.5303% | |
| -14.9506% | |
| -9.9184% | |
| -4.83% | |
| -6.0335% | |
| 6.7907% | |
| 29.0128% | |
| 20.9261% | |
| 168.8553% | |
| -5.4509% | |
| 44.9683% | |
| 60.2142% | |
| 240.9957% | |
| 63.8025% | |
| 0.938% | |
| 68.3148% | |
| 8.4998% | |
| 220.8004% | |
| 182.2769% | |
| -69.0845% | |
| -45.2748% | |
| -43.6363% | |
| -22.8015% | |
| -26.122% | |
| -35.2795% | |
| -10.0295% | |
| 244.2702% | |
| -21.9853% | |
| -12.4324% | |
| -45.2645% | |
| -6.9783% | |
| -24.2857% | |
| -5.3011% | |
| 112.9019% | |
| -17.5866% | |
| 61.1298% | |
| -43.1835% | |
| -5.0692% | |
| -23.7894% | |
| 168.8553% | |
| -42.3908% | |
| -34.7141% | |
| -18.5575% | |
| 260.936% |